CROSS COUNTRY HEALTHCARE, INC.

(CCRN)
  Report
Real-time Estimate Cboe BZX  -  09:30 2022-08-19 am EDT
24.16 USD   -1.15%
08/17CROSS COUNTRY HEALTHCARE : to Host Investor Day on September 14, 2022, Highlighting Its Innovative Strategy - Form 8-K
PU
08/17CROSS COUNTRY HEALTHCARE INC : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
08/17Cross Country Healthcare to Host Investor Day on September 14, 2022, Highlighting Its Innovative Strategy
BU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Cross Country Healthcare Announces Third Quarter 2021 Financial Results - Form 8-K

11/03/2021 | 03:48pm EDT
Cross Country Healthcare Announces Third Quarter 2021 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--November 3, 2021--Cross Country Healthcare, Inc. (the "Company") (Nasdaq: CCRN) today announced financial results for its third quarter ended September 30, 2021.

SELECTED FINANCIAL INFORMATION:

Variance

Variance

Q3 2021 vs

Q3 2021 vs

Dollars are in thousands, except per share amounts

Q3 2021

Q3 2020

Q2 2021

Revenue

$

374,905

93

%

13

%

Gross profit margin*

22.4

%

(230)

bps

50

bps

Net income attributable to common shareholders

$

23,433

1,857

%

103

%

Diluted EPS

$

0.62

$

0.66

$

0.31

Adjusted EBITDA*

$

30,127

250

%

24

%

Adjusted EBITDA margin*

8.0

%

360

bps

70

bps

Adjusted EPS*

$

0.61

$

0.49

$

0.14

Cash flows used in operations

$

(2,831)

67

%

(118)

%

* Refer to accompanying tables and discussion of non-GAAP (Generally Accepted Accounting Principles) financial measures below.

Business Highlights

  • Year-to-date revenue exceeded $1.0 billion for the first time in the Company's history
  • Year-over-year and sequential increase in volume across all segments
  • Third quarter financial performance exceeded guidance across all areas
  • Adjusted EBITDA margin exceeded 8% for the second time this year
  • Recognized as one of the top four staffing and recruiting employers for women
  • Strong double digit growth from Cross Country Workforce Solutions Group

"Our performance demonstrates the success we are having in bringing clinicians to the bedside across the nation," said Kevin Clark, Co-Founder and CEO. He continued, "Higher bill rates are really only part of the story, as the investments we have made in people and technology, along with the many changes we have made to core processes, allow us to execute more effectively. We have fundamentally transformed this company and believe we have the ability to continue to grow the number of clinicians on assignment."

Third quarter consolidated revenue was $374.9 million, an increase of 93% year-over-year and 13% sequentially. Consolidated gross profit margin was 22.4%, down 230 basis points year-over-year and up 50 basis points sequentially. Net income attributable to common shareholders was $23.4 million compared to a net loss of $1.3 million in the prior year and net income of $11.5 million in the prior quarter. Diluted earnings per share (EPS) was $0.62 per share compared to a loss of $0.04 per share in the prior year and income of $0.31 per share in the prior quarter. Adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) was $30.1 million or 8.0% of revenue, as compared with $8.6 million or 4.4% of revenue in the prior year, and $24.3 million or 7.3% of revenue in the prior quarter. Adjusted EPS was $0.61 compared to $0.12 in the prior year and $0.47 in the prior quarter.

For the nine months ended September 30, 2021, consolidated revenue was $1.0 billion, an increase of 67% year-over-year. Consolidated gross profit margin was 22.0%, down 190 basis points year-over-year. Net income attributable to common shareholders was $54.4 million, or 1.46 per diluted share, compared to a loss of $17.6 million, or 0.49 per diluted share, in the prior year. Adjusted EBITDA was $81.1 million or 7.8% of revenue, as compared with $24.8 million or 4.0% of revenue in the prior year. Adjusted EPS was $1.66 compared to $0.27 in the prior year.

Quarterly Business Segment Highlights

Nurse and Allied Staffing

Revenue was $356.1 million, an increase of 101% year-over-year and 13% sequentially. Contribution income was $40.6 million, an increase compared to $17.9 million in the prior year and $35.3 million in the prior quarter. Average field contract personnel on a full-time equivalent (FTE) basis were 9,003 as compared with 5,403 in the prior year and 7,578 in the prior quarter. Revenue per FTE per day was $425 compared to $353 in the prior year and $454 in the prior quarter. The increase in the average number of FTEs was primarily due to headcount growth in travel nurse and allied, as well as additional headcount resulting from the Cross Country Workforce Solutions Group (WSG) acquisition. In the third quarter, average bill rates rose slightly as we continued to experience higher demand and bill rates related to both COVID-19 and non-COVID-19 assignments, with a record level of demand across a wide range of specialties. Throughout the coronavirus pandemic (COVID-19), we have worked with our clients to adjust bill rates, both increasing and decreasing rates as necessary, to provide critical healthcare professionals.

Physician Staffing

Revenue was $18.8 million, an increase of 14% year-over-year and 20% sequentially. Contribution income was $0.9 million, an increase compared to $0.8 million in the prior year and $0.6 million in the prior quarter. Total days filled were 12,187 as compared with 9,682 in the prior year and 9,775 in the prior quarter. Revenue per day filled was $1,540 as compared with $1,699 in the prior year and $1,600 in the prior quarter. The increase in revenue was primarily due to an increase in volume in both primary care physicians and nurse practitioners. The increase in contribution income was driven by higher revenue, partially offset by higher direct costs.

Cash Flow and Balance Sheet Highlights

Cash flow used in operations for the quarter was $2.8 million compared to $8.5 million in the prior year and cash flow provided by operations of $15.5 million in the prior quarter, primarily due to strong sequential revenue growth which resulted in a $122.9 million increase in receivables since the start of the year. For the nine months ended September 30, 2021, cash flow used in operations was $12.3 million compared to cash flow provided by operations of $25.3 million in the prior year. Days' sales outstanding was 61 days as of September 30, 2021, down 3 days year-over-year and up 3 days since the beginning of the current year, primarily due to the timing of revenue recognized throughout the quarter given the strong monthly sequential growth through the third quarter.

At September 30, 2021, the Company had $0.8 million in cash and cash equivalents and $99.7 million principal balance on its term loan, with $4.0 million of borrowings drawn under its asset-based loan facility (ABL), and $18.5 million of letters of credit outstanding. Availability under the ABL is subject to a borrowing base, which was $149.2 million as of September 30, 2021, with $126.7 million available for borrowing as of September 30, 2021.

Outlook for Fourth Quarter 2021

The guidance below applies to management's expectations for the fourth quarter of 2021.

Q4 2021 Range

Year-over-Year

Sequential

Change

Change

Revenue

$580 million - $590 million

169% - 174%

55% - 57%

Gross Profit Margin*

22.2% - 22.7%

(300) bps - (250) bps

(20) bps - 30 bps

Adjusted EBITDA*

$63.0 million - $68.0 million

448% - 491%

109% - 126%

Adjusted EPS*

$1.01 - $1.11

$0.82 - $0.92

$0.40 - $0.50

* Refer to discussion of non-GAAP financial measures below.

The above estimates are based on current management expectations and, as such, are forward-looking and actual results may differ materially. The above ranges do not include the potential impact of any future divestitures, mergers, acquisitions, or other business combinations, changes in debt structure, or future share repurchases.

As we reported at the end of the second quarter 2021, we expected bill rates for our travel division to decline sequentially. Instead, average bill rates rose slightly during the third quarter and we expect them to rise again in the fourth quarter of 2021. We expect the pandemic to continue impacting our financial performance through at least the end of the current fiscal year. However, while COVID-19 has driven up bill rates with regional spikes in demand related to the Delta variant, the impact from states and healthcare systems enacting vaccination mandates is exacerbating an already tight supply market, and we are also experiencing growing needs in non-COVID assignments resulting in increased demand from clinicians leaving the bedside due to burnout or retirement.

See accompanying non-GAAP financial measures and tables below.

INVITATION TO CONFERENCE CALL

The Company will hold its quarterly conference call on Wednesday, November 3, 2021, at 5:00 P.M. Eastern Time to discuss its third quarter 2021 financial results. This call will be webcast live and can be accessed at the Company's website at ir.crosscountryhealthcare.com or by dialing 888-566-1290 from anywhere in the U.S. or by dialing 773-799-3776 from non-U.S. locations - Passcode: Cross Country. A replay of the webcast will be available from November 3rd through November 17th at the Company's website and a replay of the conference call will be available by telephone by calling 800-385-2541 from anywhere in the U.S. or 203-369-3263 from non-U.S. locations - Passcode: 2021.

ABOUT CROSS COUNTRY HEALTHCARE

Cross Country Healthcare, Inc. (CCH) is a leader in providing total talent management including strategic workforce solutions, contingent staffing, permanent placement, and consultative services for healthcare customers. Leveraging our 35 years of industry expertise and insight, CCH solves complex labor-related challenges for customers while providing high-quality outcomes and exceptional patient care. As a multi-year Best of Staffing® Award winner, CCH is committed to an exceptionally high level of service to both our clients and our healthcare professionals. CCH was the first publicly traded staffing firm to obtain The Joint Commission Certification, which it still holds with a Letter of Distinction. CCH was recently listed as one of the top four staffing and recruiting employers for women by InHerSights in October 2021 and earned Energage's inaugural 2021 Top Workplaces USA award in February 2021. CCH has a longstanding history of investing in its diversity, equality, and inclusion strategic initiatives as a key component of the organization's overall corporate social responsibility program which is closely aligned with its core values to create a better future for its people, communities, the planet, and its shareholders.

Copies of this and other news releases as well as additional information about the Company can be obtained online at ir.crosscountryhealthcare.com. Shareholders and prospective investors can also register to automatically receive the Company's press releases, filings with the Securities and Exchange Commission (SEC), and other notices by e-mail.

NON-GAAP FINANCIAL MEASURES

This press release and the accompanying financial statement tables reference non-GAAP financial measures, such as gross profit margin, adjusted EBITDA, and adjusted EPS. Such non-GAAP financial measures are provided as additional information and should not be considered substitutes for, or superior to, financial measures calculated in accordance with U.S. GAAP. Such non-GAAP financial measures are provided for consistency and comparability to prior year results; furthermore, management believes they are useful to investors when evaluating the Company's performance as they exclude certain items that management believes are not indicative of the Company's future operating performance. Pro forma measures, if applicable, are adjusted to include the results of our acquisitions, and exclude the results of divestments, as if the transactions occurred in the beginning of the periods mentioned. Such non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. The financial statement tables that accompany this press release include a reconciliation of each non-GAAP financial measure to the most directly comparable U.S. GAAP financial measure and a more detailed discussion of each financial measure; as such, the financial statement tables should be read in conjunction with the presentation of these non-GAAP financial measures.

FORWARD LOOKING STATEMENTS

In addition to historical information, this press release contains statements relating to our future results (including certain projections and business trends) that are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the Private Securities Litigation Reform Act, and are subject to the "safe harbor" created by those sections. Forward-looking statements consist of statements that are predictive in nature, depend upon or refer to future events. Words such as "expects", "anticipates", "intends", "plans", "believes", "estimates", "suggests", "appears", "seeks", "will", "could", and variations of such words and similar expressions are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results and performance to be materially different from any future results or performance expressed or implied by these forward-looking statements. These factors include, but are not limited to, the following: the potential impacts of the COVID-19 pandemic on our business, financial condition, and results of operations, our ability to attract and retain qualified nurses, physicians and other healthcare personnel, costs and availability of short-term housing for our travel healthcare professionals, demand for the healthcare services we provide, both nationally and in the regions in which we operate, the functioning of our information systems, the effect of cyber security risks and cyber incidents on our business, the effect of existing or future government regulation and federal and state legislative and enforcement initiatives on our business, our clients' ability to pay us for our services, our ability to successfully implement our acquisition and development strategies, including our ability to successfully integrate acquired businesses and realize synergies from such acquisitions, the effect of potential liabilities, losses, or other exposures in connection with the WSG acquisition, the effect of liabilities and other claims asserted against us, the effect of competition in the markets we serve, our ability to successfully defend the Company, its subsidiaries, and its officers and directors on the merits of any lawsuit or determine its potential liability, if any, and other factors set forth in Item 1A. "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2020, and in our other filings with the SEC. You should consult any further disclosures the Company makes on related subjects in its filings with the SEC.

Although we believe that these statements are based upon reasonable assumptions, we cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management's opinions only as of the date of this press release. There can be no assurance that (i) we have correctly measured or identified all of the factors affecting our business or the extent of these factors' likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct, and/or (iv) our strategy, which is based in part on this analysis, will be successful. The Company undertakes no obligation to update or revise forward-looking statements. All references to "we", "us", "our", or "Cross Country" in this press release mean Cross Country Healthcare, Inc. and its subsidiaries.

Cross Country Healthcare, Inc.

Consolidated Statements of Operations

(Unaudited, amounts in thousands, except per share data)

Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2021

2020

2021

2021

2020

Revenue from services

$

374,905

$

193,968

$

331,827

$

1,035,973

$

620,811

Operating expenses:

Direct operating expenses

291,111

145,965

259,237

808,124

472,471

Selling, general and administrative expenses

52,847

40,804

50,344

149,518

128,939

Bad debt expense

1,441

946

466

2,411

2,383

Depreciation and amortization

2,680

3,247

2,199

7,132

10,472

Acquisition and integration-related costs

61

-

924

985

77

Restructuring costs

318

2,316

835

2,391

5,210

Impairment charges

-

1,071

1,921

2,070

16,082

Total operating expenses

348,458

194,349

315,926

972,631

635,634

Income (loss) from operations

26,447

(381

)

15,901

63,342

(14,823

)

Other expenses (income):

Interest expense

2,182

608

1,196

4,049

2,219

Other income, net

(375

)

(10

)

(204

)

(616

)

(46

)

Income (loss) before income taxes

24,640

(979

)

14,909

59,909

(16,996

)

Income tax expense (benefit)

1,207

169

3,361

5,480

(32

)

Consolidated net income (loss)

23,433

(1,148

)

11,548

54,429

(16,964

)

Less: Net income attributable to noncontrolling interest in subsidiary

-

186

-

-

610

Net income (loss) attributable to common shareholders

$

23,433

$

(1,334

)

$

11,548

$

54,429

$

(17,574

)

Net income (loss) per share attributable to common shareholders - Basic

$

0.63

$

(0.04

)

$

0.32

$

1.49

$

(0.49

)

Net income (loss) per share attributable to common shareholders - Diluted

$

0.62

$

(0.04

)

$

0.31

$

1.46

$

(0.49

)

Weighted average common shares outstanding:

Basic

36,963

36,176

36,625

36,593

36,058

Diluted

37,582

36,176

37,203

37,276

36,058

Cross Country Healthcare, Inc.

Reconciliation of Non-GAAP Financial Measures

(Unaudited, amounts in thousands, except per share data)

Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2021

2020

2021

2021

2020

Adjusted EBITDA:a

Net income (loss) attributable to common shareholders

$

23,433

$

(1,334

)

$

11,548

$

54,429

$

(17,574

)

Interest expense

2,182

608

1,196

4,049

2,219

Income tax expense (benefit)

1,207

169

3,361

5,480

(32

)

Depreciation and amortization

2,680

3,247

2,199

7,132

10,472

Acquisition and integration-related costsb

61

-

924

985

77

Restructuring costsc

318

2,316

835

2,391

5,210

Legal settlements and feesd

(1,556

)

837

28

(1,153

)

2,398

Impairment chargese

-

1,071

1,921

2,070

16,082

Other income, net

(375

)

(10

)

(204

)

(616

)

(46

)

Equity compensation

1,771

1,064

2,137

5,257

4,063

Applicant tracking system costsf

406

444

315

1,096

1,343

Net income attributable to noncontrolling interest in subsidiaryg

-

186

-

-

610

Adjusted EBITDAa

$

30,127

$

8,598

$

24,260

$

81,120

$

24,822

Adjusted EBITDA margina

8.0

%

4.4

%

7.3

%

7.8

%

4.0

%

Adjusted EPS:h

Numerator:

Net income (loss) attributable to common shareholders

$

23,433

$

(1,334

)

$

11,548

$

54,429

$

(17,574

)

Non-GAAP adjustments - pretax:

Acquisition and integration-related costsb

61

-

924

985

77

Restructuring costsc

318

2,316

835

2,391

5,210

Legal settlements and feesd

(1,556

)

837

28

(1,153

)

2,398

Impairment charges (excluding rebranding impacts)e

-

1,071

1,921

2,070

16,082

Rebranding impairments and accelerated amortizatione

-

938

-

-

3,075

Applicant tracking system costsf

406

444

315

1,096

1,343

Nonrecurring income tax adjustmentsi

-

-

1,942

1,942

313

Tax impact of non-GAAP adjustments

(1

)

(20

)

(11

)

(14

)

(990

)

Adjusted net income attributable to common shareholders - non-GAAP

$

22,661

$

4,252

$

17,502

$

61,746

$

9,934

Denominator:

Weighted average common shares - basic, GAAP

36,963

36,176

36,625

36,593

36,058

Dilutive impact of share-based paymentsj

619

228

578

683

253

Adjusted weighted average common shares - diluted, non-GAAP

37,582

36,404

37,203

37,276

36,311

Reconciliation:

Diluted EPS, GAAP

$

0.62

$

(0.04

)

$

0.31

$

1.46

$

(0.49

)

Non-GAAP adjustments - pretax:

Acquisition and integration-related costsb

-

-

0.03

0.03

-

Restructuring costsc

0.01

0.06

0.02

0.06

0.14

Legal settlements and feesd

(0.03

)

0.03

-

(0.02

)

0.07

Impairment charges (excluding rebranding impacts)e

-

0.03

0.05

0.05

0.45

Rebranding impairments and accelerated amortizatione

-

0.03

-

-

0.09

Applicant tracking system costsf

0.01

0.01

0.01

0.03

0.03

Nonrecurring income tax adjustmentsi

-

-

0.05

0.05

0.01

Tax impact of non-GAAP adjustments

-

-

-

-

(0.03

)

Adjusted EPS, non-GAAPh

$

0.61

$

0.12

$

0.47

$

1.66

$

0.27

Cross Country Healthcare, Inc.

Consolidated Balance Sheets

(Unaudited, amounts in thousands)

September 30,

December 31,

2021

2020

Assets

Current assets:

Cash and cash equivalents

$

842

$

1,600

Accounts receivable, net

301,040

170,003

Prepaid expenses

3,418

5,455

Insurance recovery receivable

4,655

4,698

Other current assets

3,318

1,355

Total current assets

313,273

183,111

Property and equipment, net

14,877

12,351

Operating lease right-of-use assets

8,064

10,447

Goodwill

112,990

90,924

Trade names, indefinite-lived

5,900

5,900

Other intangible assets, net

44,145

34,831

Other non-current assets

21,171

19,409

Total assets

$

520,420

$

356,973

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable and accrued expenses

$

73,033

$

49,877

Accrued employee compensation and benefits

54,875

35,540

Current portion of debt

3,426

2,425

Operating lease liabilities - current

4,362

4,509

Current portion of earnout liability

7,500

-

Other current liabilities

1,466

1,072

Total current liabilities

144,662

93,423

Long-term debt, less current portion

98,665

53,408

Operating lease liabilities - non-current

12,280

15,234

Non-current deferred tax liabilities

9,388

6,592

Long-term accrued claims

25,521

25,412

Long-term contingent consideration

7,500

-

Other long-term liabilities

5,605

7,995

Total liabilities

303,621

202,064

Commitments and contingencies

Stockholders' equity:

Common stock

4

4

Additional paid-in capital

318,415

310,388

Accumulated other comprehensive loss

(1,312

)

(1,280

)

Accumulated deficit

(100,308

)

(154,737

)

Total Cross Country Healthcare, Inc. stockholders' equity

216,799

154,375

Noncontrolling interest in subsidiary

-

534

Total stockholders' equity

216,799

154,909

Total liabilities and stockholders' equity

$

520,420

$

356,973

Cross Country Healthcare, Inc.

Segment Datak

(Unaudited, amounts in thousands)

Three Months Ended

Year-over-
Year

Sequential

September 30,


% of

September 30,


% of

June 30,


% of

% change

% change

2021


Total

2020


Total

2021


Total

Fav (Unfav)

Fav (Unfav)




Revenue from services:




Nurse and Allied Staffing

$

356,139


95

%

$

177,516


91

%

$

316,188


95

%

101

%

13

%

Physician Staffing

18,766


5

%

16,452


9

%

15,639


5

%

14

%

20

%

$

374,905


100

%

$

193,968


100

%

$

331,827


100

%

93

%

13

%




Contribution income:l




Nurse and Allied Staffing

$

40,645


$

17,925


$

35,284


127

%

15

%

Physician Staffing

910


827


562


10

%

62

%

41,555


18,752


35,846


122

%

16

%







Corporate overheadm

12,049


12,499


14,066


4

%

14

%

Depreciation and amortization

2,680


3,247


2,199


17

%

(22)

%

Acquisition and integration-related costsb

61


-


924


(100)

%

93

%

Restructuring costsc

318


2,316


835


86

%

62

%

Impairment chargese

-


1,071


1,921


100

%

100

%

Income (loss) from operations

$

26,447


$

(381

)


$

15,901


NM

66

%







Nine Months Ended

Year-over-
Year

September 30,


% of

September 30,


% of

% change

2021


Total

2020


Total

Fav (Unfav)




Revenue from services:




Nurse and Allied Staffing

$

985,335


95

%

$

569,306


92

%


73

%

Physician Staffing

50,638


5

%

51,505


8

%


(2)

%

$

1,035,973


100

%

$

620,811


100

%


67

%




Contribution income:l




Nurse and Allied Staffing

$

113,346


$

51,334



121

%

Physician Staffing

2,900


2,677



8

%

116,246


54,011



115

%







Corporate overheadm

40,326


36,993



(9)

%

Depreciation and amortization

7,132


10,472



32

%

Acquisition and integration-related costsb

985


77



NM

Restructuring costsc

2,391


5,210



54

%

Impairment chargese

2,070


16,082



87

%

Income (loss) from operations

$

63,342


$

(14,823

)



527

%




NM-Not meaningful.




Cross Country Healthcare, Inc.

Summary Condensed Consolidated Statements of Cash Flows

(Unaudited, amounts in thousands)

Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2021

2020

2021

2021

2020

Net cash (used in) provided by operating activities

$

(2,831

)

$

(8,456

)

$

15,505

$

(12,253

)

$

25,275

Net cash used in investing activities

(1,888

)

(1,169

)

(26,286

)

(29,360

)

(3,659

)

Net cash (used in) provided by financing activities

(12,569

)

6,818

15,434

40,869

(19,183

)

Effect of exchange rate changes on cash

3

19

(14

)

(14

)

(19

)

Change in cash and cash equivalents

(17,285

)

(2,788

)

4,639

(758

)

2,414

Cash and cash equivalents at beginning of period

18,127

6,234

13,488

1,600

1,032

Cash and cash equivalents at end of period

$

842

$

3,446

$

18,127

$

842

$

3,446

Cross Country Healthcare, Inc.

Other Financial Data

(Unaudited)

Three Months Ended

Nine Months Ended

September 30,

September 30,

June 30,

September 30,

September 30,

2021

2020

2021

2021

2020

Consolidated gross profit marginn

22.4

%

24.7

%

21.9

%

22.0

%

23.9

%

Nurse and Allied Staffing statistical data:

FTEso

9,003

5,403

7,578

7,732

6,116

Average Nurse and Allied Staffing revenue per FTE per dayp

$

425

$

353

$

454

$

462

$

335

Physician Staffing statistical data:

Days filledq

12,187

9,682

9,775

31,430

29,077

Revenue per day filledr

$

1,540

$

1,699

$

1,600

$

1,611

$

1,771

(a)


Adjusted EBITDA, a non-GAAP financial measure, is defined as net income (loss) attributable to common shareholders before interest expense, income tax expense (benefit), depreciation and amortization, acquisition and integration-related costs, restructuring costs, legal settlements and fees, impairment charges, gain or loss on derivative, loss on early extinguishment of debt, gain or loss on disposal of fixed assets, gain or loss on sale of business, other expense (income), net, equity compensation, applicant tracking system costs, and includes net income attributable to noncontrolling interest in subsidiary. Adjusted EBITDA should not be considered a measure of financial performance under GAAP. Management presents Adjusted EBITDA because it believes that Adjusted EBITDA is a useful supplement to net income attributable to common shareholders as an indicator of operating performance. Management uses Adjusted EBITDA for planning purposes and as one performance measure in its incentive programs for certain members of its management team. Adjusted EBITDA, as defined, closely matches the operating measure as defined by the Company's credit facilities. Adjusted EBITDA Margin is calculated by dividing Adjusted EBITDA by the Company's consolidated revenue.

(b)


Acquisition and integration-related costs include costs for legal and advisory fees for the WSG acquisition that closed on June 8, 2021, and valuation adjustments related to the contingent consideration liability for the Mediscan acquisition.

(c)


Restructuring costs are primarily comprised of employee termination costs, lease-related exit costs, and reorganization costs as part of planned cost savings initiatives.

(d)


Legal settlements and fees include legal settlement charges as presented on the consolidated statements of operations as well as legal fees pertaining to non-operational legal matters outside the normal course of operations which are included in selling, general and administrative expenses. For the nine months ended September 30, 2021, legal settlements and fees resulted in a net benefit of $1.2 million due to a recovery in the third quarter of $1.6 million. For the nine months ended September 30, 2020, we incurred $2.4 million in legal fees related to an ongoing legal matter outside the normal course of operations.

(e)


Impairment charges for the nine months ended September 30, 2021 were comprised of $1.9 million related to right-of-use assets and related property in connection with leases that were vacated during the second quarter and $0.1 million related to the write-off of a discontinued software development project. Impairment charges in 2020 of $16.1 million were comprised of $10.7 million primarily related to goodwill and other intangible assets for the former Search business and $5.4 million related to right-of-use assets and related property and equipment in connection with leases that were vacated during the second and third quarters. Rebranding impairments and accelerated amortization related to finite-lived trade names in connection with the rebranding initiatives.

(f)


Applicant tracking system costs are related to the Company's project to replace its legacy system supporting its travel nurse staffing business. These costs are reported in selling, general and administrative expenses on the consolidated statement of operations and included in corporate overhead in segment data.

(g)


Cross Country Talent Acquisition Group, LLC was controlled by the Company but not wholly owned. The Company recorded the ownership interest of the noncontrolling shareholder as noncontrolling interest in subsidiary. Effective December 31, 2020, the sole professional staffing services agreement held by this joint venture was terminated and, as a result, the Company dissolved Cross Country Talent Acquisition Group, LLC in the third quarter of 2021. The Company subsequently entered into a direct staffing agreement with the hospital system.

(h)


Adjusted EPS, a non-GAAP financial measure, is defined as net income (loss) attributable to common shareholders per diluted share before the diluted EPS impact of acquisition and integration-related costs, restructuring costs, legal settlements and fees, impairment charges, rebranding impairments and accelerated amortization, gain or loss on derivative, loss on early extinguishment of debt, gain or loss on sale of business, applicant tracking system costs, and nonrecurring income tax adjustments. Adjusted EPS should not be considered a measure of financial performance under GAAP. Management presents Adjusted EPS because it believes that Adjusted EPS is a useful supplement to its reported EPS as an indicator of operating performance. Management believes it provides a more useful comparison of the Company's underlying business performance from period to period and is more representative of the future earnings capacity of the Company.

(i)


Non-recurring income tax adjustment for the nine months ended September 30, 2021 reflects a valuation allowance related to a state rate change as a result of the WSG acquisition.

(j)


Due to the net loss for the three and nine months ended September 30, 2020, 228 and 253 shares (in thousands) were excluded from diluted weighted average shares.

(k)


Segment data provided is in accordance with the Segment Reporting Topic of the FASB ASC. In the first quarter of 2021, the Company modified its reportable segments and now discloses two reportable segments - Nurse and Allied Staffing and Physician Staffing beginning in the first quarter of 2021. Revenue in the amount of $2.3 million and $7.7 million, respectively, and contribution loss of $0.3 million and $1.7 million, respectively, included in the previously-reported Search segment have been reclassified to Nurse and Allied Staffing for the three and nine months ended September 30, 2020.

(l)


Contribution income is defined as income (loss) from operations before depreciation and amortization, acquisition and integration-related costs, restructuring costs, legal settlement charges, impairment charges, and corporate overhead. Contribution income is a financial measure used by management when assessing segment performance.

(m)


Corporate overhead includes unallocated executive leadership and other centralized corporate functional support costs such as finance, IT, legal, human resources, and marketing, as well as public company expenses and corporate-wide projects (initiatives).

(n)


Gross profit is defined as revenue from services less direct operating expenses. The Company's gross profit excludes allocated depreciation and amortization expense. Gross profit margin is calculated by dividing gross profit by revenue from services.

(o)


FTEs represent the average number of Nurse and Allied Staffing contract personnel on a full-time equivalent basis.

(p)


Average revenue per FTE per day is calculated by dividing Nurse and Allied Staffing revenue, excluding permanent placement, per FTE by the number of days worked in the respective periods.

(q)


Days filled is calculated by dividing the total hours invoiced during the period, including an estimate for the impact of accrued revenue, by 8 hours.

(r)


Revenue per day filled is calculated by dividing revenue as reported by days filled for the period presented.

Contacts

Cross Country Healthcare, Inc.
William J. Burns, Executive Vice President & Chief Financial Officer
561-237-2555
wburns@crosscountry.com

Disclaimer

Cross Country Healthcare Inc. published this content on 03 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 November 2021 20:45:32 UTC.


© Publicnow 2021
All news about CROSS COUNTRY HEALTHCARE, INC.
08/17CROSS COUNTRY HEALTHCARE : to Host Investor Day on September 14, 2022, Highlighting Its In..
PU
08/17CROSS COUNTRY HEALTHCARE INC : Regulation FD Disclosure, Financial Statements and Exhibits..
AQ
08/17Cross Country Healthcare to Host Investor Day on September 14, 2022, Highlighting Its I..
BU
08/16CROSS COUNTRY HEALTHCARE : Announces Authorization of a New $100 Million Stock Repurchase ..
PU
08/16Cross Country Healthcare Sets New $100 Million Share Buyback Program
MT
08/16CROSS COUNTRY HEALTHCARE INC : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
08/16Cross Country Healthcare, Inc. announces an Equity Buyback for $100 million worth of it..
CI
08/16Cross Country Healthcare Announces Authorization of a New $100 Million Stock Repurchase..
BU
08/16Cross Country Healthcare, Inc. authorizes a Buyback Plan.
CI
08/15CROSS COUNTRY HEALTHCARE : to Attend The 15th Annual Barrington Research Virtual Fall Conf..
PU
More news
Analyst Recommendations on CROSS COUNTRY HEALTHCARE, INC.
More recommendations
Financials (USD)
Sales 2022 2 671 M - -
Net income 2022 177 M - -
Net Debt 2022 159 M - -
P/E ratio 2022 5,22x
Yield 2022 -
Capitalization 934 M 934 M -
EV / Sales 2022 0,41x
EV / Sales 2023 0,36x
Nbr of Employees 2 250
Free-Float 96,4%
Chart CROSS COUNTRY HEALTHCARE, INC.
Duration : Period :
Cross Country Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CROSS COUNTRY HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBearishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 7
Last Close Price 24,44 $
Average target price 35,00 $
Spread / Average Target 43,2%
EPS Revisions
Managers and Directors
John A. Martins President, Chief Executive Officer & Director
William J. Burns Executive VP, Chief Financial & Accounting Officer
Kevin C. Clark Chairman
Henry Drummond Chief Clinical Officer & Senior Vice President
Phillip Noe Chief Information Officer
Sector and Competitors
1st jan.Capi. (M$)
CROSS COUNTRY HEALTHCARE, INC.-11.96%934
RANDSTAD N.V.-19.39%8 971
ROBERT HALF INTERNATIONAL, INC-27.39%8 731
ADECCO GROUP AG-29.83%5 962
PERSOL HOLDINGS CO., LTD.-13.08%4 955
MANPOWERGROUP INC.-17.40%4 160